Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sébastien Tardy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chimia|December 9, 2023
Linkers as Game-changers in PROTAC Technology: Emphasizing General Trends in PROTAC Pharmacokinetics for their Rational DesignCarlotta Cecchini, Sébastien Tardy, Leonardo Scapozza
Frontiers in Chemistry|May 7, 2021
From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein DegradationCarlotta Cecchini, Sara Pannilunghi, Sébastien Tardy, et al.
Chimia|April 26, 2020
Exploring the Ubiquitin-Proteasome System (UPS) through PROTAC TechnologyCarlotta Cecchini, Sébastien Tardy, Valentina Ceserani, et al.
Frontiers in Chemistry|June 12, 2024
Study of phenoxy radical couplings using the enzymatic secretome of <i>Botrytis cinerea</i>Robin Huber, Laurence Marcourt, Fabien Félix, et al.
Bioorganic & Medicinal Chemistry|January 29, 2014
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitorsSébastien Tardy, Alexandre Orsato, Luca Mologni, et al.
Journal of Medicinal Chemistry|January 24, 2025
Discovery of the First Efficacious Adenosine 2A Receptor Negative Allosteric Modulators for High Adenosine Cancer ImmunotherapiesMargot Boujut, Margaux Héritier, Aurélie Gouiller, et al.
Frontiers in Pharmacology|August 23, 2021
Novel Mechanism for an Old Drug: Phenazopyridine is a Kinase Inhibitor Affecting Autophagy and Cellular DifferentiationOlivier Preynat-Seauve, Evelyne Bao-Vi Nguyen, Yvonne Westermaier, et al.
ACS Omega|June 1, 2022
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma KinaseLuca Mologni, Sébastien Tardy, Alfonso Zambon, et al.
European Journal of Medicinal Chemistry|June 6, 2022
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinaseLuca Mologni, Alexandre Orsato, Alfonso Zambon, et al.
Journal of Medicinal Chemistry|January 6, 2016
In Silico Driven Design and Synthesis of Rhodanine Derivatives as Novel Antibacterials Targeting the Enoyl Reductase InhALiudas Slepikas, Gianpaolo Chiriano, Remo Perozzo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chimia|December 9, 2023
Linkers as Game-changers in PROTAC Technology: Emphasizing General Trends in PROTAC Pharmacokinetics for their Rational DesignCarlotta Cecchini, Sébastien Tardy, Leonardo Scapozza
Frontiers in Chemistry|May 7, 2021
From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein DegradationCarlotta Cecchini, Sara Pannilunghi, Sébastien Tardy, et al.
Chimia|April 26, 2020
Exploring the Ubiquitin-Proteasome System (UPS) through PROTAC TechnologyCarlotta Cecchini, Sébastien Tardy, Valentina Ceserani, et al.
Frontiers in Chemistry|June 12, 2024
Study of phenoxy radical couplings using the enzymatic secretome of <i>Botrytis cinerea</i>Robin Huber, Laurence Marcourt, Fabien Félix, et al.
Bioorganic & Medicinal Chemistry|January 29, 2014
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitorsSébastien Tardy, Alexandre Orsato, Luca Mologni, et al.
Journal of Medicinal Chemistry|January 24, 2025
Discovery of the First Efficacious Adenosine 2A Receptor Negative Allosteric Modulators for High Adenosine Cancer ImmunotherapiesMargot Boujut, Margaux Héritier, Aurélie Gouiller, et al.
Frontiers in Pharmacology|August 23, 2021
Novel Mechanism for an Old Drug: Phenazopyridine is a Kinase Inhibitor Affecting Autophagy and Cellular DifferentiationOlivier Preynat-Seauve, Evelyne Bao-Vi Nguyen, Yvonne Westermaier, et al.
ACS Omega|June 1, 2022
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma KinaseLuca Mologni, Sébastien Tardy, Alfonso Zambon, et al.
European Journal of Medicinal Chemistry|June 6, 2022
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinaseLuca Mologni, Alexandre Orsato, Alfonso Zambon, et al.
Journal of Medicinal Chemistry|January 6, 2016
In Silico Driven Design and Synthesis of Rhodanine Derivatives as Novel Antibacterials Targeting the Enoyl Reductase InhALiudas Slepikas, Gianpaolo Chiriano, Remo Perozzo, et al.
Pageof 2